Leveraging the unique insights of its founders and an internal team of outstanding scientists, the Company seeks to become an industry leader in the neural stem cell field with
multiple therapeutic product candidates ranging from epilepsy and neuropathic pain to other potential opportunities in the broader neurodegenerative and neuropsychiatric disease space.
Non-exclusive licenses are available for research and sale of
products and services across
multiple fields including: research tools, kits, reagents; discovery of novel targets for
therapeutic intervention; cell lines for discovery and screening of novel drug candidates; GMP production of healthcare
products; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology.